News
-
-
-
-
PRESS RELEASE
Alzchem Group AG paves the way for continuity and further growth: Management Board contracts of Andreas Niedermaier and Andreas Lösler extended ahead of schedule
Alzchem Group AG extends Management Board contracts of Andreas Niedermaier and Andreas Lösler ahead of schedule to ensure continuity and future growth -
-
PRESS RELEASE
ENOGIA: ENOGIA secures €2 million in financing from Vatel Capital, which can be increased to €3 million - Transaction to support the Turbo 2028 plan
ENOGIA secures €2 million in financing from Vatel Capital, with potential increase to €3 million, to support the Turbo 2028 plan. Strong commercial performance confirmed by recent contracts, particularly in South Korea -
-
PRESS RELEASE
Aramis Group - Declaration of transactions on own shares conducted from Dec 15 to Dec 19, 2025
Aramis Group declares recent purchases of own shares (FR0014003U94) conducted from December 15 to December 19, 2025, in compliance with regulations. More details on the transactions available on their website -
PRESS RELEASE
AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040
AB Science's patent for masitinib in the treatment of sickle cell disease is formally granted in the United States, providing long-term protection until 2040. The biomarker Phase 2 in cooperation with AP-HP is fully funded -
